Back to results
US 2013/0157859 A1Published application
Hybrid caulimovirus promoters and constructs thereof
AssigneeMonsanto Technology LLC
InventorsKaren L. Fincher, Stanislaw Flasinski, Jack Q. Wilkinson
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel hybrid promoters comprising a caulimovirus promoter operably linked to one or more of an EF1α, Act8, Act2 or Act11 promoter. The present invention also relates to novel DNA constructs comprising at least one expression cassette which comprises the hybrid promoter thereof. The present invention further relates to transgenic plants/seeds comprising such DNA constructs.
Claims22
1-23. (canceled)
A nucleic acid molecule comprising SEQ ID NO:28.
44-47. (canceled)
Dependencies are inferred from the claim text.